Funded Tech Companies
Stealth BioTherapeutics
Wondering who provided funding to Stealth BioTherapeutics? UK Research and Innovation, BVCF and Ocean Partners joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Stealth BioTherapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
275 Grove St. 3-107
Newton, MA 02466
USA
Newton, MA 02466
USA
Phone
Website
Email Address
Company Background Information
Overview
Stealth BioTherapeutics (Nasdaq: MITO) is an innovative biopharmaceutical company committed to bringing patients mitochondria-targeted therapies to treat both common and rare diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/23/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reenie McCarthy
Chief Financial Officer
Daniel Geffken
Chief Scientific Officer
Mark Bamberger
Vice President
Deb Gouveia
VP - Bus. Development
Brian Blakey
VP - General Counsel
Henry Hess
VP - Operations
Marty Redmon
VP - Regulatory Affairs
David Schubert
Company Investors
- UK Research and Innovation
- BVCF
- Ocean Partners
- Morningside Group
- Pivotal bioVenture Partners (Vincent Cheung)
- Sagamore Ventures
- Atlantis Investment Management
- CMBC Capital Holdings
- Kingdon Capital
Browse more funded tech companies:
Stealth Biosciences | Stealth Security
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs